Boston Scientific (BSX) Q2 2018 Results - Earnings Call Transcript

7/26/18

Boston Scientific Corp. (NYSE:BSX) Q2 2018 Earnings Call July 25, 2018 8:00 AM ET

Executives

Susan Vissers Lisa - Boston Scientific Corp.

Michael F. Mahoney - Boston Scientific Corp.

Daniel J. Brennan - Boston Scientific Corp.

Ian T. Meredith - Boston Scientific Corp.

Kenneth Stein, M.D. - Boston Scientific Corp.

Analysts

David Ryan Lewis - Morgan Stanley & Co. LLC

Glenn John Novarro - RBC Capital Markets LLC

Frederick Wise - Stifel, Nicolaus & Co., Inc.

Lawrence Biegelsen - Wells Fargo Securities LLC

Joanne Karen Wuensch - BMO Capital Markets (United States)

Robert J. Marcus - JPMorgan Securities LLC

Christopher Pasquale - Guggenheim Securities LLC

Bruce M. Nudell - SunTrust Robinson Humphrey, Inc.

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Boston Scientific Q2 2018 earnings call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will be given at that time. As a reminder, today's call is being recorded.

I will now turn the conference over to your host, Susan Lisa. Please go ahead.

Susan Vissers Lisa - Boston Scientific Corp.

Thank you, Kevin. Good morning, everyone, and thanks for joining us. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer, and Dan Brennan, Executive Vice President and Chief Financial Officer.

We issued a press release earlier this morning announcing our Q2 2018 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Financial Information.

READ FULL ARTICLE HERE